Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-35.35M
↑ 15% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-41.63M
Historical baseline
PeriodValueYoY Change
TTM$-35.35M+11.9%
2024$-40.14M-45.1%
2023$-27.66M+17.3%
2022$-33.45M-25.5%
2021$-26.65M-44.9%
2020$-18.39M+57.7%
2019$-43.52M-61.1%
2018$-27.01M+67.9%
2017$-84.27M-5.6%
2016$-79.82M-